Healthcare company DexCom, Inc. (NASDAQ: DXCM) reported a double-digit increase in second-quarter earnings and also provided full-year guidance.
- Second-quarter revenue grew 25% year-over-year to $871.3 million, on a reported basis, and 26% on an organic basis
- U.S. revenue rose 21%; international revenue increased 38% on a reported basis and 40% on an organic basis
- Operating income increased sharply to $128.1 million in Q2 from $77.0 million in the prior-year quarter
- Q2 net income was $115.9 million or $0.28 per share, compared to $50.9 million or $0.12 per share in the same quarter of 2022
- As of June 30, Dexcom held $3.64 billion in cash, cash equivalents, and marketable securities
- For fiscal 2023, the management expects total revenue to be in the range of $3.500 billion to 3.550 billion, which represents a 20-22% growth
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Earnings Preview: Fastenal Company likely to report higher Q2 sales and profit
Fastenal Company (NASDAQ: FAST), a leading provider of industrial and construction supplies, is set to publish its second-quarter results next week. The company is among the hardest hit by the
What to look for when Netflix (NFLX) reports its Q2 2025 earnings results
Shares of Netflix, Inc. (NASDAQ: NFLX) stayed red on Monday. The stock has gained 50% over the past three months. The streaming giant is scheduled to report its earnings results
Coinbase shines on stablecoin boom, S&P 500 debut. Will the rally continue?
Coinbase Global, Inc. (NASDAQ: COIN) has emerged as the largest and most user-friendly cryptocurrency exchange in the US, since going public a few years ago. It has played a pivotal
